LIN vs SCL · P/E 34, rev $33.99B vs P/E 22, rev $2.18B
Linde plc Ordinary Shares (LIN) versus Stepan Company (SCL) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Not investment advice. Open the LIN and SCL stock pages for the full models.
Not investment advice.